Controlling cell biomechanics in orthopaedic tissue engineering and repair.
Tissue engineering offers an alternative approach with great potential for the treatment or replacement of damaged tissues or organs. In contrast to current treatments, a small sample of cells can be collected from the patient and cultured in vitro, greatly increasing the number of cells available for engineering tissue implants. As a result, engineered tissue implants limit the problems associated with patient trauma and undesirable immune response currently observed in surgical treatments practised in tissue and organ replacement. Mechano-transduction is known to play an essential role in bone tissue remodelling and repair. At physiological magnitudes, the effects of secondary messenger pathways, their components and local mediators generated as a direct result of mechanical load are known to result in an elevation of specific matrix protein mRNAs. Up-regulation of matrix protein production is paramount to tissue formation. Thus, mechano-transduction offers a method of producing bone tissue in vitro. However, successful transduction of mechanical stimuli from a substrate to cells is reliant upon a number of factors including cell-substrate adhesion, scaffold material mechanics and the activation of membrane channels, for example voltage-operated calcium channels (VOCC). Our research focuses on the optimisation of mechano-transduction pathways for successful bone tissue engineering. In this paper, we focus on the effects of cell-substrate adhesion, attenuation of VOCC activation states and biological conditioning of cell-scaffold constructs utilising bioreactors in relation to mechano-transduction-induced bone tissue production. The effects of these factors on successful bone tissue formation observed in increased matrix protein synthesis due to the optimisation of mechano-transduction pathways is discussed.
El Haj
Alicia J
AJ
Institute of Science and Technology in Medicine, Keele University Medical School, University Hospital of North Staffordshire, Hartshill, Stoke-on-Trent ST4 7QB, UK. bea17@keele.ac.uk
Wood
Mairead A
MA
Thomas
Peter
P
Yang
Ying
Y
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D019149:Bioreactors; D001857:Bone Matrix / Q000378:metabolism; D002120:Calcium Channel Agonists / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology; D002448:Cell Adhesion; D018929:Cell Culture Techniques / Q000295:instrumentation / Q000379:methods; D002460:Cell Line; D002478:Cells, Cultured / Q000637:transplantation; D005898:Glass; D006801:Humans; D018472:Hypogravity; D040542:Mechanotransduction, Cellular; D019637:Orthopedic Procedures / Q000379:methods*; D009985:Orthopedics; D011108:Polymers; D011312:Pressure; D013499:Surface Properties; D023822:Tissue Engineering / Q000295:instrumentation / Q000379:methods*; D014182:Transplantation, Autologous
D002120:Calcium Channel Agonists; D015220:Calcium Channels; D011108:Polymers; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester